Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:1333-1336
Published online before print May 21, 2009, doi: 10.1161/CIRCRESAHA.109.196154
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/12/1333    most recent
CIRCRESAHA.109.196154v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ahmed, A.
Right arrow Articles by Kontos, C. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, A.
Right arrow Articles by Kontos, C. D.
Related Collections
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2009;104:1333.)
© 2009 American Heart Association, Inc.


Report

Angiopoietin-2 Confers Atheroprotection in apoE–/– Mice by Inhibiting LDL Oxidation via Nitric Oxide

Asif Ahmed, Takeshi Fujisawa*, Xi-Lin Niu*, Shakil Ahmad*, Bahjat Al-Ani, Kunal Chudasama, Allyah Abbas, Rahul Potluri, Vineet Bhandari, Clarence M. Findley, Gregory K.W. Lam, Jianhua Huang, Peter W. Hewett, Melissa Cudmore, Christopher D. Kontos

From the Reproductive and Vascular Biology (A. Ahmed, T.F., S.A., B.A.-A., K.C., A. Abbas, R.P., P.H., M.C.), Institute for Biomedical Research, University of Birmingham, United Kingdom; Division of Cardiology (X.-L.N., C.M.F., G.K.W.L., J.H., C.D.K.), Duke University Medical Center, Durham, NC; and Department of Pediatrics (V.B.), Yale University, New Haven, Conn.

Correspondence to Professor Asif Ahmed, Institute for Biomedical Research, University of Birmingham, Birmingham, B15 2TT, United Kingdom. E-mail a.s.ahmed{at}bham.ac.uk

Atherosclerosis is promoted by a combination of hypercholesterolemia and vascular inflammation. The function of Angiopoietin (Ang)-2, a key regulator of angiogenesis, in the maintenance of large vessels is unknown. A single systemic administration of Ang-2 adenovirus (AdAng-2) to apoE–/– mice fed a Western diet significantly reduced atherosclerotic lesion size ({approx}40%) and oxidized LDL and macrophage content of the plaques. These beneficial effects were abolished by the inhibition of nitric oxide synthase (NOS). In endothelial cells, endothelial NOS activation per se inhibited LDL oxidation and Ang-2 stimulated NO release in a Tie2-dependent manner to decrease LDL oxidation. These findings demonstrate a novel atheroprotective role for Ang-2 when endothelial cell function is compromised and suggest that growth factors, which stimulate NO release without inducing inflammation, could offer atheroprotection.


Key Words: angiopoietin-2 • atherosclerosis • endothelial cells • LDL cholesterol • nitric oxide • nitric oxide synthases